English
Home > Products > 81058-27-7

China 81058-27-7 Factory

We've been experienced manufacturer. Wining the majority on the crucial certifications of its market for 81058-27-7,CAS NO 81058-27-7,Canagliflozin intermediate,Canagliflozin advance intermediate,2,3,4,6-Tetra-O-pivaloyl, Top quality and competitive rates make our products and solutions appreciate a higher name all around the word.
81058-27-7, Our company always concentrate on the development of the international market. We've got a lot of customers in Russia , European countries, the USA, the Middle East countries and Africa countries. We always follow that quality is foundation while service is guarantee to meet all customers.

Related Products

Hot Products

  • Desmopressin acetate

    Desmopressin acetate

    Product Name:Desmopressin acetate
    Molecular Formula:C48H68N14O14S2
    Molecular Weight;1129.28
    CAS Registry Number;16789-98-3
  • (S)-[2-(Benzyloxy)propylidene]hydrazinecarboxaldehyde

    (S)-[2-(Benzyloxy)propylidene]hydrazinecarboxaldehyde

    Product Name:(S)-[2-(Benzyloxy)propylidene]hydrazinecarboxaldehyde
    Molecular Formula:C11H14N2O2
    Molecular Weight:206.24
    CAS Registry Number:170985-84-9
  • thiosemicarbazide

    thiosemicarbazide

    Product Name:thiosemicarbazide
    Molecular Formula:CH5N3S
    Molecular Weight;91.14
    CAS Registry Number;79-19-6
  • 3,4-Dichloronitrobenzene

    3,4-Dichloronitrobenzene

    Product Name:3,4-Dichloronitrobenzene
    Molecular Formula:C6H3Cl2NO2
    Molecular Weight:192
    CAS Registry Number:99-54-7
  • Halometasone

    Halometasone

    Product Name:Halometasone
    Molecular Formula:C22H27ClF2O5
    Molecular Weight;444.9
    CAS Registry Number;50629-82-8
  • Lithium

    Lithium

    Product Name:Lithium
    Molecular Formula:Li
    Molecular Weight:6.941
    CAS Registry Number:7439-93-2
  • Related Blog
  • Reviews

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

Related Search

CAS NO 81058-27-7

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept